Focusing on patient safety & improving health outcomes is an important part of the work we do every day. At API, one of our services include Pharmacokinetic (PK) analysis, a review of data to determine the recommended dosage and regimen for drugs. This is a key step in ensuring safety of patients when consuming prescription drugs and it is an important part of our drug development process.
In this video, Micheal Guirguis’s sheds light on his work at API and the work we’re doing to help patients feel better.
About Micheal Guirguis
Micheal Guirguis is the Director, Clinical Pharmacology & Data at Applied Pharmaceutical Innovation. With over two decades of experience in pharmacokinetics and Pharmacodynamics for drug discovery and drug development process, Micheal leads the design and preparation of clinical pharmacokinetics, clinical study reports, integrated summary documents, development strategies and study protocols at API.
He is passionate about empowering students, recent graduates, and postdoctoral fellows and through his extensive experience in PK/PD, he plays a key role in training them on industry projects through API and helping them begin their careers in the life sciences and pharmaceutical industry.